Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial
Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share up to USD$1.48 early on in the trading day. Solid Liquidity Position The company reported a stellar liquidity position at the end of the fourth quarter of fiscal 2021, with cash […]
Clovis Oncology, Inc. (CLVS) Stock Soars Amid Continuing Meme Stock Phenomenon
Clovis Oncology, Inc. (CLVS) stock prices were up by 4.77% as of the market closing on June 8th, 2021, bringing the price per share up to USD$5.71 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by a significant 18.21% bringing it up to USD$6.75. Get the hottest stocks […]
Aethlon Medical, Inc. (AEMD) Stock Skyrockets Following Success of Hemopurifier Treatment in Covid-19 Patient
Aethlon Medical, Inc. (AEMD) stock prices were up by a marginal 0.45% as of the market closing on June 8th, 2021, bringing the price per share up to USD$2.21 at the end of the trading day. After-hours trading saw the stock skyrocket by an astounding 92.31%, bringing it up to USDS$4.25. EUA for Hemopurifier The […]
PDS Biotechnology Corp. (PDSB) Stock Rallies Following Inclusion in Russell Microcap Index
PDS Biotechnology Corp. (PDSB) stock prices were down by a concerning 26.45% as of the market closing on June 7th, 2021, bringing the price per share down to USD$9.40 at the end of the trading day. Subsequent pre-market fluctuations saw the stock rise by 8.51%, bringing it up to USD$10.20. Inclusion in Russell Microcap Index […]
Cullinan Oncology, Inc. (CGEM) Stock Surges Following Positive Supplementary CLN-081 Study Information
Cullinan Oncology, Inc. (CGEM) stock prices were up by 18.63% shortly after market trading commenced on June 4th, 2021, bringing the price per share up to USD$35.30 early on in the trading day. CLN-081 Trial Update The oncology company announced supplementary information about Cullinan Pearl’s ongoing Phase 1/2a trial of CLN-081 on June 4th, 2021. […]
Leap Therapeutics, Inc. (LPTX) Stock Poised to Rise Following Surge in Trading Volume
Leap Therapeutics, Inc. (LPTX) stock prices were own by a marginal 0.62% as of the market closing on June 3rd, 2021, bringing the price per share down to USD$1.61. After-hours trading saw the stock surge by 14.91%, bringing it up to USD$1.85. Net Loss Reports Net loss reported for the first quarter of the fiscal […]
BriaCell Therapeutics Corp. (BCTX) Stock Skyrockets Following Disclosure of Overall Survival (OS) Reports
BriaCell Therapeutics Corp. (BCTX) stock prices were down by a marginal 2.75% as of the market closing on June 1st, 2021, bringing the price per share up to USD$3.18 at the end of the trading day. Subsequent current market fluctuations have seen the stock skyrocket by 99.69% to hit USD$6.35. OS Update The clinical stage […]
Purple Biotech Ltd. (PPBT) Stock Undergoes Minor Volatility Amid Progression of CM24 Clinical Trial
Purple Biotech Ltd. (PPBT) stock prices were up by 2.15% as of the market closing on May 26th, 2021, bringing the price per share up to USD$4.76 at the end of the trading day. Subsequent pre-market fluctuations saw the price dip by a marginal 1.05%, bringing it down to USD$4.71. CM24 Trial Commences Patient Dosing […]
AnPac Bio-Medical Science Co., Ltd. (ANPC) Stock Surges Following Announcement of Joint Venture
AnPac Bio-Medical Science Co., Ltd. (ANPC) stock prices were up by 3.08% as of the market closing on May 24th, 2021, bringing the price per share up to USD$4.68 at the end of the trading day. Subsequent pre-market fluctuations saw the stock skyrocket by 19.87%, bringing it up to USD$5.61. Joint Venture Approved The company’s […]
Hoth Therapeutics, Inc. (HOTH) Stock Poised to Surge Pending Orphan Drug Designation Approval
Hoth Therapeutics, Inc. (HOTH) stock prices were up by 6.43% as of the market closing on May 21st, 2021, bringing the price per share up to USD$1.49 at the end of the trading day. Subsequent pre-market fluctuations saw the price fall by a marginal 2.68%, bringing it down to USD$1.45. HT-KIT HOTH announced early in […]
